A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder

BACKGROUND: Buprenorphine treatment is not equally effective in all patients with opioid use disorder (OUD). Two retrospective studies showed that, among African Americans (AAs), rs678849, a polymorphism in the delta-opioid receptor gene, moderated the therapeutic effect of sublingual buprenorphine....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Neuropsychopharmacol
Asıl Yazarlar: Kranzler, Henry R, Lynch, Kevin G, Crist, Richard C, Hartwell, Emily, Le Moigne, Anne, Laffont, Celine M, Andorn, Anne C
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Regular Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883889/
https://ncbi.nlm.nih.gov/pubmed/32920647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyaa069
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller